DOK7 congenital myasthenic syndrome in childhood: Early diagnostic clues in 23 children

DOK7 congenital myasthenic syndrome in childhood: Early diagnostic clues in 23 children

Εμφάνιση άλλων εκδόσεων (1)

Mutations in DOK7 are a common cause of congenital myasthenia. Treatment with ephedrine or salbutamol is effective, but diagnosis is often delayed. The aim of our study was to find early clues to the diagnosis of DOK7 congenital myasthenic syndrome. We included 23 children of 20 families. Onset of s...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Klein, A, Pitt, M, McHugh, J, Niks, E, Sewry, C, Phadke, R, Feng, L, Manzur, A, Tirupathi, S, DeVile, C, Jayawant, S, Finlayson, S, Palace, J, Muntoni, F, Beeson, D, Robb, SA
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2013

Παρόμοια τεκμήρια

DOK7 congenital myasthenic syndrome in childhood: early diagnostic clues in 23 children.
ανά: Klein, A, κ.ά.
Έκδοση: (2013)

Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations.
ανά: Burke, G, κ.ά.
Έκδοση: (2013)

Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
ανά: Lashley, D, κ.ά.
Έκδοση: (2010)

Congenital stridor with feeding difficulty as a presenting symptom of Dok7 congenital myasthenic syndrome.
ανά: Jephson, C, κ.ά.
Έκδοση: (2010)

DOK7 congenital myasthenic syndrome.
ανά: Palace, J
Έκδοση: (2012)

Congenital myasthenic syndromes in childhood: diagnostic and management challenges.
ανά: Kinali, M, κ.ά.
Έκδοση: (2008)

The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.
ανά: Cossins, J, κ.ά.
Έκδοση: (2012)

Congenital myasthenic syndromes: an update.
ανά: Finlayson, S, κ.ά.
Έκδοση: (2013)

Dok-7/MuSK signaling and a congenital myasthenic syndrome.
ανά: Yamanashi, Y, κ.ά.
Έκδοση: (2008)

EPHEDRINE TREATMENT RESULTS IN PROFOUND FUNCTIONAL IMPROVEMENTS IN DOK-7 CONGENITAL MYASTHENIA
ανά: Lashley, D, κ.ά.
Έκδοση: (2009)

Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes.
ανά: Müller, J, κ.ά.
Έκδοση: (2007)

DOK7 Mutations in Congenital Myasthenic Syndromes
ανά: J Gordon Millichap
Έκδοση: (2007-06-01)

The spectrum of mutations that underlie the DOK7 neuromuscular junction synaptopathy, and the patient response to treatment
ανά: Beeson, D, κ.ά.
Έκδοση: (2012)

CLINICAL FEATURES OF THE SLOW-CHANNEL CONGENITAL MYASTHENIC SYNDROME
ανά: Lashley, D, κ.ά.
Έκδοση: (2009)

A nationwide service for the diagnosis and treatment of congenital myasthenic syndromes
ανά: Burke, G, κ.ά.
Έκδοση: (2006)

Clinical features of the DOK7 neuromuscular junction synaptopathy.
ανά: Palace, J, κ.ά.
Έκδοση: (2007)

Muscle magnetic resonance imaging in congenital myasthenic syndromes
ανά: Finlayson, S, κ.ά.
Έκδοση: (2016)

Mutations in dok-7 underlie a congenital myasthenic syndrome with a (sic)Limb girdle broken vertical bar pattern of muscle weakness.
ανά: Beeson, D, κ.ά.
Έκδοση: (2006)

The congenital myasthenic syndromes.
ανά: Palace, J, κ.ά.
Έκδοση: (2008)

Ephedrine treatment in DOK7 CMS and investigation of potential mechanisms
ανά: Cossins, J, κ.ά.
Έκδοση: (2010)

Congenital myasthenic syndromes.
ανά: Beeson, D, κ.ά.
Έκδοση: (1997)

DOK7 congenital myasthenic syndrome: case series and review of literature
ανά: Bentolhoda Ziaadini, κ.ά.
Έκδοση: (2024-06-01)

FAST CHANNEL CONGENITAL MYASTHENIA: REVIEW OF 12 CASES AND TREATMENT CHALLENGES
ανά: Finlayson, S, κ.ά.
Έκδοση: (2012)

Congenital myasthenic syndromes and the neuromuscular junction.
ανά: Cruz, P, κ.ά.
Έκδοση: (2014)

Therapeutic strategies for congenital myasthenic syndromes
ανά: Lee, M, κ.ά.
Έκδοση: (2018)

Effects of beta-2 adrenergic receptor agonists in DOK7 congenital myasthenic syndrome
ανά: Clausen, L
Έκδοση: (2015)

Congenital Myasthenic Syndrome due to DOK7 mutations in a family from Chile
ανά: Jorge A. Bevilacqua, κ.ά.
Έκδοση: (2017-09-01)

Congenital myasthenic syndromes: Epidemiology, clinical phenotyping and aids to diagnosis in the neuromuscular clinic
ανά: Healy, E, κ.ά.
Έκδοση: (2014)

Congenital myasthenic syndrome caused by mutations in DPAGT.
ανά: Klein, A, κ.ά.
Έκδοση: (2015)

Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol.
ανά: Finlayson, S, κ.ά.
Έκδοση: (2013)

Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome.
ανά: Belaya, K, κ.ά.
Έκδοση: (2012)

The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes
ανά: Rodríguez Cruz, P, κ.ά.
Έκδοση: (2018)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1
ανά: Finlayson, S, κ.ά.
Έκδοση: (2013)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1.
ανά: Finlayson, S, κ.ά.
Έκδοση: (2013)

Chronic stridor as an early presentation of congenital myasthenic syndrome due to RAPSN mutation
ανά: Mewasingh, L, κ.ά.
Έκδοση: (2006)

THE CLINICAL PHENOTYPIC SPECTRUM OF GFPT1 ASSOCIATED CONGENITAL MYASTHENIC SYNDROME
ανά: Chaouch, A, κ.ά.
Έκδοση: (2012)

Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myasthenia.
ανά: Munot, P, κ.ά.
Έκδοση: (2010)

Therapy of myasthenic syndrome
ανά: Palace, J
Έκδοση: (2012)

Congenital myasthenia: contrasting rapsyn and Dok-7 phenotypes
ανά: Palace, J
Έκδοση: (2010)

Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7.
ανά: Hamuro, J, κ.ά.
Έκδοση: (2008)